ESR1 and breast carcinoma: Concerning breast cancer, SOD2 expression levels are different in the various histotypes, being upregulated in both tissue specimens and cell lines derived from the more “aggressive” basal-like, claudin low-, and estrogen receptor-negative subtype, including MDA-MB231 [25].